KR20180096201A - A composition having antiviral activity for white spot syndrome virus - Google Patents
A composition having antiviral activity for white spot syndrome virus Download PDFInfo
- Publication number
- KR20180096201A KR20180096201A KR1020170022579A KR20170022579A KR20180096201A KR 20180096201 A KR20180096201 A KR 20180096201A KR 1020170022579 A KR1020170022579 A KR 1020170022579A KR 20170022579 A KR20170022579 A KR 20170022579A KR 20180096201 A KR20180096201 A KR 20180096201A
- Authority
- KR
- South Korea
- Prior art keywords
- preventing
- white spot
- treating
- mixture
- shrimp
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 104
- 241000696962 White spot syndrome virus Species 0.000 title claims abstract description 72
- 230000000840 anti-viral effect Effects 0.000 title abstract description 19
- 241000238557 Decapoda Species 0.000 claims abstract description 110
- 239000000284 extract Substances 0.000 claims abstract description 30
- 208000015181 infectious disease Diseases 0.000 claims abstract description 30
- 238000000576 coating method Methods 0.000 claims abstract description 18
- 239000011248 coating agent Substances 0.000 claims abstract description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 15
- 229940010454 licorice Drugs 0.000 claims abstract description 15
- 235000018597 common camellia Nutrition 0.000 claims abstract description 13
- 240000001548 Camellia japonica Species 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 3
- 241000700605 Viruses Species 0.000 claims description 42
- 241000238424 Crustacea Species 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 21
- 241000202807 Glycyrrhiza Species 0.000 claims description 14
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- 241000238017 Astacoidea Species 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000003674 animal food additive Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims 4
- 235000019693 cherries Nutrition 0.000 claims 4
- 229920001477 hydrophilic polymer Polymers 0.000 claims 4
- 206010034960 Photophobia Diseases 0.000 claims 2
- 239000002861 polymer material Substances 0.000 claims 2
- 235000007516 Chrysanthemum Nutrition 0.000 claims 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- 235000011511 Diospyros Nutrition 0.000 claims 1
- 244000236655 Diospyros kaki Species 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 235000019504 cigarettes Nutrition 0.000 claims 1
- 229940066901 crestor Drugs 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- LALFOYNTGMUKGG-BGRFNVSISA-L rosuvastatin calcium Chemical compound [Ca+2].CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O.CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O LALFOYNTGMUKGG-BGRFNVSISA-L 0.000 claims 1
- 239000000419 plant extract Substances 0.000 abstract description 65
- 241001646648 Aesculus turbinata Species 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract description 2
- 244000163122 Curcuma domestica Species 0.000 abstract description 2
- 239000003443 antiviral agent Substances 0.000 abstract description 2
- 235000003373 curcuma longa Nutrition 0.000 abstract description 2
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 241000393483 Dryopteris crassirhizoma Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 244000222996 Syzygium nervosum Species 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 238000011081 inoculation Methods 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 241000519995 Stachys sylvatica Species 0.000 description 19
- 230000001186 cumulative effect Effects 0.000 description 16
- 230000004083 survival effect Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000004372 Polyvinyl alcohol Substances 0.000 description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000001856 Ethyl cellulose Substances 0.000 description 6
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229920001249 ethyl cellulose Polymers 0.000 description 6
- 235000019325 ethyl cellulose Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000209507 Camellia Species 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241001137251 Corvidae Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000013505 freshwater Substances 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000058338 Macrobrachium nipponense Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000184734 Pyrus japonica Species 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000701447 unidentified baculovirus Species 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 241000238553 Litopenaeus vannamei Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 240000003296 Petasites japonicus Species 0.000 description 2
- 241000663306 Trachysalambria curvirostris Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000254171 Curculionidae Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241000534017 Saururus chinensis Species 0.000 description 1
- 244000045719 Syzygium Species 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 241000411751 Trachypenaeus curvirostris Species 0.000 description 1
- 241001058063 Whispovirus Species 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/04—Pteridophyta [fern allies]; Filicophyta [ferns]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Abstract
Description
본 발명은 흰반점 바이러스 (WSSV, White spot syndrome virus) 감염에 따른 질환을 예방 또는 치료하기 위한 항바이러스 조성물에 관한 것이다. The present invention relates to an antiviral composition for preventing or treating diseases caused by white spot syndrome virus (WSSV) infection.
새우 흰반점 바이러스 (White spot syndrome virus, WSSV) 전세계에 폭넓게 분포되어 있는 바이러스로서, 바이론 말단 부위에 꼬리와 유사한 부착물을 갖고, 로드 (rod) 형태의 캡시드 (capsid) 및 엔벨롭 (envelop)이 존재하는 난형의 바실러스와 유사한 형태를 갖고 있다. 이러한 구조적인 특징으로 인해, 베큘로바이러스 또는 바실러스 유사형 바이러스 (bacillus-like formed virus)로 불렸으나, 최근 유전학적으로 새로운 바이러스 그룹인 휘스포바이러스 (whispovirus)로 명명되고 있다 (van Hulten M.C., et al.,J. Gen. Virol., 81(Pt2), pp307-16, 2000). 흰반점 바이러스는 길이 약 275 nm, 직경 약 120 nm 이고, 약 290 kb의 크기를 갖는 2중 나선 DNA (double-stranded DNA)로 구성된다. WSSV는 주로 새우, 가재, 및 게 등의 갑각류에 감염되며, 특히, 새우에 감염되면 새우의 갑피 (carapace), 외지 (appendage) 및 큐티클에 흰반점이 나타나고, 새우의 간 췌장 (hepatopancreas)이 붉은색을 띠게 된다. 흰반점은 칼슘염의 축적이며 갑각의 내측표면에서 가장 선명하게 형성된다. 감염된 새우는 무기력해지며 섭식을 중단하고 수표면을 느리게 움직이다가 사망한다. 감염 후 3 ~ 10일 내에 80 ~ 100% 폐사되며, 20일 이내에 전량 폐사되는 등, 새우류에 있어 매우 치명적인 감염성 질환이다. 현재 WSSV는 전세계적으로 발생하고 있으며, 양식새우에 많은 피해를 주고 있음에도 불구하고 아직 뚜렷한 대책이 없는 실정이다. White spot syndrome virus (WSSV) is a virus widely distributed throughout the world. It has a tail-like attachment at the end of the viaon, and a rod-shaped capsid and envelope exist Which is similar to that of egg-shaped bacillus. Due to this structural feature, it has been called baculovirus or bacillus-like formed virus, but recently it has been named as a genetically new virus group, whispovirus (van Hulten MC, et al., J. Gen. Virol., 81 (Pt2), pp307-16, 2000). The white spot virus is composed of double-stranded DNA with a length of about 275 nm and a diameter of about 120 nm and a size of about 290 kb. WSSV is mainly infected with crustaceans such as shrimp, crayfish, and crabs. Especially, when the shrimp is infected, white spots appear on the carapace, appendage and cuticle of shrimp, and hepatopancreas of shrimp are red Color. White spots are accumulations of calcium salts and are most clearly formed on the inner surface of the carapace. Infected shrimps become lethargic, stop feeding, move slowly on the surface of water, and die. It is an extremely infectious disease in shrimp such as 80 ~ 100% dead within 3 ~ 10 days after infection and all dead within 20 days. Currently, WSSV is occurring all over the world, and although it does a lot of damage to aquaculture shrimp, there is no clear measure yet.
새우류에 대한 질병 종류가 100여 가지로 알려져 있으나, 그 중 WSSV에 의한 피해가 가장 심각한 것으로 보고되고 있다. 이에 많은 나라에서 흰반점 바이러스에 대한 연구를 수행하고 있으며, 바이러스의 검사 방법과 생물학적 특성을 밝히는 연구들이 활발히 진행되고 있다. 그러나, 새우의 면역체계는 척추동물과 상이하여, 백신 개발에 많은 어려움이 있다. 척추동물에 감염되는 병원체의 대부분은 숙주에서 항체가 생성되면 쇠퇴하다가 다시 창궐하는 양상을 보이나, WSSV에 대한 저항성을 갖는 새우가 나타났다는 보고는 아직 없다. 국내에서는 글루칸 (Glucan) 제제를 사료에 첨가하여 면역능력을 향상시키거나, 염소소독제로 새우의 입식 전에 입식공간을 소독하여 바이러스를 소멸시키기도 하지만 뚜렷한 효과를 보지 못하고 있다. 또한, 한국특허등록 제 10-0824106호는 제비쑥 추출물 및 삼백초 추출물이 흰반점 바이러스에 대한 항바이러스 활성을 갖는 것을 개시한 바 있다. 이 밖에도 감초, 천궁, 땅콩, 메밀, 청각, 및 김 추출물 등이 흰반점바이러스에 대한 억제 활성을 갖는 것으로 보고된 바 있다. 그러나, 흰반점 바이러스의 예방이나 치료에 대한 획기적인 방법은 현재까지 개발되지 못하고 있는 실정이다.Although there are more than 100 kinds of diseases related to shrimp, it is reported that the damage caused by WSSV is the most serious. In many countries, white spot viruses have been studied, and studies have been actively conducted to identify viruses and their biological properties. However, the immune system of shrimp is different from vertebrate animals, and there are many difficulties in vaccine development. Most of the pathogens infected with vertebrate animals show a tendency to recede after antibody production in the host, but there is no report that shrimps resistant to WSSV have appeared. In Korea, glucan (Glucan) is added to feed to enhance immunity, or as a chlorine disinfectant, it disinfects the storage space before shrimp ingestion, but it does not have any clear effect. In addition, Korean Patent Registration No. 10-0824106 discloses that Zygomycetes japonica extract and Saururus chinensis extract have antiviral activity against white spot virus. In addition, licorice, licorice, peanut, buckwheat, hearing, and Kim extract have been reported to have inhibitory activity against white spot viruses. However, epoch-making methods for the prevention and treatment of white spot virus have not been developed to date.
본 발명의 목적은 흰반점 바이러스 (WSSV, White spot syndrome virus)에 대한 억제 활성이 있는 신규 항바이러스 조성물을 제공하는 것이다.It is an object of the present invention to provide a novel antiviral composition having inhibitory activity against white spot syndrome virus (WSSV).
본 발명의 다른 목적은 흰반점 바이러스에 대한 억제 활성이 있는 신규 항바이러스 조성물로서 식물추출물의 혼합물을 제공하는 것이다.Another object of the present invention is to provide a mixture of plant extracts as a novel antiviral composition with inhibitory activity against white spot viruses.
본 발명의 다른 목적은 갑각류에서 흰반점 바이러스에 의한 감염을 예방 또는 치료하기 위한 방법을 제공하는 것이다.Another object of the present invention is to provide a method for preventing or treating an infection caused by white spot virus in crustaceans.
상기 본 발명의 목적을 달성하기 위해, 본 발명은 식물추출물의 혼합물을 포함하는, 새우 및 가재 등 갑각류에서 흰반점 바이러스에 의한 감염증을 예방 또는 치료하기 위한 식물추출물의 혼합물인 항바이러스 조성물을 제공한다. In order to achieve the object of the present invention, the present invention provides an antiviral composition comprising a mixture of plant extracts, which is a mixture of plant extracts for preventing or treating infections caused by white spot viruses in crustaceans such as shrimp and crayfish .
상기 식물추출물의 혼합물은 관중, 크레이스토카릭스 오페르쿠라투스, 칠엽수, 감초, 울금, 백지 및 동백 중 어느 하나에 대한 추출물을 혼합한 것 또는 상기 중, 관중, 크레이스토카릭스 오페르쿠라투스, 칠엽수, 감초, 울금, 백지 및 동백을 일괄하여 추출한 추출물로서의 혼합물일 수 있다. 즉, 상기 관중, 크레이스토카릭스 오페르쿠라투스, 칠엽수, 감초, 울금, 백지 및 동백 각각에 대한 추출물을 혼합할 수 있고, 상기 관중, 크레이스토카릭스 오페르쿠라투스, 칠엽수, 감초, 울금, 백지 및 동백을 일괄하여 추출한 혼합물일 수 있으며, 각각의 추출물을 혼합한 경우에는 각각의 추출물의 각 성분이 제조되는 과정에서 보다 순수한 추출물일 수 있다. 한편, 일괄하여 추출하는 경우에는 각 성분의 일괄 추출 시에 여러 성분이 함께 추출되는 과정에서 미세한 효과의 차이가 있을 수 있다. The mixture of the above plant extracts may be a mixture of extracts for one of the crows, Craystokarix auxercuratus, Chilobar, Licorice, Ulvae, White paper and Camellia, or a mixture of the above-mentioned crowns, Craistocarix auxercutatus , Chickwood, licorice, kelp, white paper, and camellia. That is, it is possible to mix the extracts for each of the above-mentioned crows, Craystokarix operkurtus, Chilobar, Licorice, Ulgum, White paper and Camellia, and the above-mentioned crows, Craystokarix auxercutus, , White paper, and camellia. When each of the extracts is mixed, each component of each extract may be a pure extract in the process of production. On the other hand, in the case of extracting in a batch, there may be a slight difference in the effect of extracting various components together at the time of extracting each component.
상기 식물추출물의 혼합물은 관중추출물 : 크레이스토카릭스 오페르쿠라투스 추출물 : 칠엽수 추출물 : 감초 추출물 : 울금 추출물 :백지 추출물 : 동백 추출물 = 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0의 중량비를 갖는 것이 바람직하다. 또한, 상기 식물추출물의 혼합물은 관중추출물 : 크레이스토카릭스 오페르쿠라투스 추출물 : 칠엽수 추출물 : 감초 추출물: 울금 추출물 = 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0의 중량비를 갖고 일괄하여 추출하는 것이 바람직하다. 또한, 상기 천연물로부터 성분을 추출할 때, 정제수, 에틸아세테이트, 부틸아세테이트, 메틸알콜, 프로판올, 이소프로필알콜 및 부틸알코올 중 어느 하나 또는 이들의 2이상의 혼합물이 추출용매로 사용되어 상기 식물추출물의 혼합물이 제조될 수 있다. 이 때, 상기 식물추출물의 혼합물은 관중, 크레이스토카릭스 오페르쿠라투스, 칠엽수, 감초, 울금, 백지 및 동백 중 어느 하나를 각각 추출한 후에 혼합할 수 있으며, 동시에 추출용매를 사용하여 추출할 수 있다.1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 3.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0. 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0, and it is preferable that they are collectively extracted. Further, when extracting the component from the natural product, any one of purified water, ethyl acetate, butyl acetate, methyl alcohol, propanol, isopropyl alcohol and butyl alcohol, or a mixture of two or more thereof is used as an extraction solvent, Can be produced. At this time, the mixture of the plant extracts can be mixed with each other after extracting one of the crows, Craystokarix operculus, Chilobus, Licorice, Ulgus, White paper and Camellia, have.
또한, 본 발명은 식물추출물의 혼합물을 이용하여 새우 및 가재 등 갑각류에서 흰반점 바이러스에 의한 감염증을 예방 또는 치료하기 위한 방법을 제공한다. 본 발명에서, 새우 등에 대한 흰반점 바이러스에 의한 감염을 예방 및 치료하기 위한 목적으로 공급되는 식물추출물의 혼합물은 사료 1톤당 100 내지 1,000 g로 포함될 수 있다. The present invention also provides a method for preventing or treating infections caused by white spot viruses in crustaceans such as shrimp and lobster using a mixture of plant extracts. In the present invention, a mixture of plant extracts supplied for the purpose of preventing and treating infections caused by white spot virus on shrimp, etc., may be contained in an amount of 100 to 1,000 g per 1 ton of feed.
본 발명의 일 예에서, 본 발명자들은 꽃새우와 한국의 토종 민물새우인 징거미 새우를 대상으로, 이들 새우에 WSSV를 감염시킨 다음, 식물추출물 혼합물의 바이러스 억제 활성을 확인한다. 구체적으로, 본 발명에서 새우를 감염시키는데 사용한 바이러스는, WSSV에 감염된 흰다리 새우로부터 분리한 것을 이용한다. 상기 흰다리 새우로부터 분리한 바이러스를 꽃새우 또는 징거미 새우에 주사기로 접종하여 감염시킨다. 새우를 감염시키기 위한 WSSV 접종량은 5.8 X 103 copy/㎖ 이고, 새우 1 g당 바이러스 100 ㎕를 접종하며, 이는 새우의 누적 폐사율이 약 80%에 이르는 수준의 바이러스 양이다. 식물추출물 혼합물의 바이러스 억제 활성을 확인하기 위해, WSSV 접종 전부터 본 발명의 식물추출물의 혼합물을 일반 새우사료와 함께 공급한다. In one example of the present invention, the present inventors have examined the virus-inhibiting activity of the plant extract mixture after infecting the shrimp with WSSV, which is a native shrimp of Korean native shrimp. Specifically, the virus used for infecting shrimp in the present invention is a virus isolated from P. vannamei-infected P. vannamei. The virus isolated from the P. vannamei is inoculated with a syringe and infected with a flower or a shrimp. The amount of WSSV inoculated to infect shrimp is 5.8 × 10 3 copy / ㎖, and 100 μl of virus is inoculated per 1 g of shrimp, which is the amount of virus in which the cumulative mortality rate of shrimp is about 80%. In order to confirm the viral inhibitory activity of the plant extract mixture, a mixture of the plant extract of the present invention is supplied together with the general shrimp feed before the WSSV inoculation.
본 발명의 다른 일 예에서, 식물추출물의 혼합물은 시판 중인 새우사료와 함께 코팅하여 이용할 수 있다. 본 발명에서, 징거미 새우에 대한 항바이러스 활성은 추출물을 코팅하여 사용한 반면, 꽃새우에 대한 항바이러스 활성은 상기 추출물의 혼합물을 코팅하지 않은 상태로 사용하였다. 식물추출물 혼합물을 코팅처리 한 것은 추출물 특유의 향을 차단함으로써, 새우 등의 섭식을 현저히 개선할 수 있다. In another example of the present invention, a mixture of plant extracts may be used by coating with commercially available shrimp feeds. In the present invention, the antiviral activity against the shrimp was used with coating of the extract, while the antiviral activity against the shrimp was used without coating the mixture of the extract. The coating treatment of the plant extract mixture can significantly reduce the ingestion of shrimp and the like by blocking the fragrance peculiar to the extract.
코팅의 방법으로는 폴리비닐알코올 (Sigma, P8136)에 항바이러스 추출물을 7:1 ~ 11:1의 비율로 혼합한 후 일반사료 (대하플러스 4호, 우성사료)에 코팅한 후 건조기에 1일 내지 2일 동안 건조시킨다. 완전히 건조된 상태에서 에틸 셀룰로오스 (Duksan, 5148)를 알코올과 아세톤의 혼합용액에 완전히 용해시킨 후 항바이러스 추출물이 코팅된 일반사료 총 중량의 5 ~ 15%를 분사해 코팅시킬 수 있다. 2단계의 코팅처리를 하면 상기 식물추출물 혼합물 특유의 향을 완전히 차폐할 뿐만 아니라 사료의 안정성을 향상시키는데 도움을 줄 수 있다. As a coating method, antiviral extract was mixed with polyvinyl alcohol (Sigma, P8136) at a ratio of 7: 1 to 11: 1 and then coated on a general feed (Daeha Plus No. 4, dominant feed) ≪ / RTI > to 2 days. After completely dissolving ethyl cellulose (Duksan, 5148) in a mixed solution of alcohol and acetone in a completely dried state, it is possible to spray 5-15% of the total weight of the general feed coated with the antiviral extract. The two-step coating treatment can not only completely block the unique flavor of the plant extract mixture but also help improve the stability of the feed.
본 발명의 일 예에서, 본 발명의 항바이러스 활성을 갖는 식물추출물의 혼합물은 바이러스 억제 활성이 요구되는 제품으로서, 사료첨가제 조성물, 화장료 조성물, 또는 소독제조성물 등의 제조에 사용될 수 있다. 소독제 조성물로 사용되는 경우, 약리학적, 수의학적 또는 농학적으로 허용 가능한 담체 또는 희석제를 함께 포함할 수 있음은 물론이다.In one example of the present invention, a mixture of plant extracts having an antiviral activity of the present invention is a product requiring a virus-suppressing activity and can be used for the production of a feed additive composition, a cosmetic composition, a disinfectant composition and the like. When used as a disinfecting composition, it is of course possible to include a pharmacologically, veterinarily or agriculturally acceptable carrier or diluent.
본 발명에서 꽃새우 (Trachypenaeus curvirostris)와 징거미새우 (Macrobrachium nipponense)를 사용하고, 실험실에서 7종의 식물추출물 혼합물에 대해 효용성 평가를 실시하였으며, 그 결과 공격접종군 대비 60% 이상의 상대생존율을 확인하였다. In the present invention, the effectiveness of the mixture of seven plant extracts in the laboratory was evaluated using Trachypenaeus curvirostris and Macrobrachium nipponense. As a result, the relative survival rate was confirmed to be 60% or more of the attacked group.
본 발명에 따르면, 본 발명의 식물추출물 혼합물은 새우사료와 함께 이용함으로써 새우에 대한 흰반점 바이러스 감염을 효과적으로 예방 또는 치료할 수 있다. 또한, 본 발명의 식물추출물 혼합물은 폴리비닐알코올로 1차 코팅한 후 에틸 셀룰로오스로 2차 코팅하여 제조될 수 있으며, 이는 식물추출물 특유의 냄새를 차폐하여 새우의 섭식을 개선할 수 있다. According to the present invention, the plant extract mixture of the present invention can be effectively used in combination with shrimp feed to prevent or treat white spot virus infection on shrimp. In addition, the plant extract mixture of the present invention can be prepared by first coating with polyvinyl alcohol, followed by secondary coating with ethylcellulose, which can improve shrimp feeding by shielding the odor of the plant extract.
도 1은 본 발명에서 사용한 꽃새우 (Trachysalambria curvirostris)의 사진이다.
도 2는 본 발명에서 사용한 징거미새우 (Macrobrachium nipponense)의 사진이다.
도 3은 본 발명의 식물추출물 혼합물의 코팅 전후를 비교한 사진이다.
도 4는 본 발명의 식물추출물 혼합물을 이용한 항바이러스 활성 실험에서, 흰반점 바이러스에 감염된 꽃새우의 상대적 생존율을 나타낸 그래프이다.
도 5는 본 발명의 식물추출물 혼합물을 이용한 항바이러스 활성 실험에서, 흰반점 바이러스에 감염된 징거미 새우의 상대적 생존율을 나타낸 그래프이다.
도 6은 PCR을 이용한 WSSV 감염여부를 확인한 것으로서, 레인 1 및 2 는 WSSV를 징거미 새우에 접종한 군이고, 레인 3 및 4는 WSSV 접종 전 개체군이다.
도 7은 WSSV 공격접종 후 징거미 새우의 WSSV 감염여부를 PCR로 확인한 것으로서, 초기 (2 ~ 5일째), 중기 (6 ~ 10일 째), 및 후기 (11 ~ 14일 째)의 결과를 나타낸 것이다.Fig. 1 is a photograph of a giant tortoise ( Trachysalambria curvirostris ) used in the present invention.
Fig. 2 is a photograph of a shrimp ( Macrobrachium nipponense ) used in the present invention.
FIG. 3 is a photograph of a plant extract mixture of the present invention before and after coating. FIG.
FIG. 4 is a graph showing the relative survival rate of the white spot virus-infected female shrimp in the antiviral activity test using the plant extract mixture of the present invention.
FIG. 5 is a graph showing the relative survival rate of P. japonica shrimp infected with white spot virus in the antiviral activity test using the plant extract mixture of the present invention.
FIG. 6 shows the results of confirming the presence of WSSV infection by PCR.
FIG. 7 shows PCR results of WSSV infection of P. japonica after the inoculation with WSSV, showing the results of the early (2-5 days), middle (6-10 days), and late (11-14 days) .
이하, 본 발명을 구체적인 실시예에 기초하여 보다 상세히 설명한다. 하기 실시예는 본 발명의 이해를 돕기 위한 것일 뿐, 본 발명의 권리범위가 이에 제한되는 것으로 해석되는 것은 아니다.Hereinafter, the present invention will be described in more detail based on specific examples. The following examples are provided to aid understanding of the present invention and are not to be construed as limiting the scope of the present invention.
실험 재료 및 실험 방법Materials and Experiments
공격접종용 흰반점 바이러스의 분리Isolation of white spot virus for attack inoculation
WSSV 감염된 흰다리새우 (Litopenaues vannamei)에서 분리한 것을 사용하였고, 부경대학교 미생물학과로부터 입수하였고, Stock된 WSSV의 바이러스 역가 (titer)는 1.16 X 106 copy/㎖이다. TNE buffer(50mM Tris-HCl, 400mM NaCl, 5mM EDTA, 1mM proteinase inhibitor PMSF, PH 8.5)에 20배 희석하여 1 ㎖ (26 게이지) 주사기를 사용하여 새우 체중 1 g당 100 ㎕를 접종하였다. 새우에 접종된 WSSV의 최종농도는 새우 1 g당 5.8 X 103 copy/100 ㎕이며, 해당 바이러스는 징거미 새우에 공격접종 하였을 시 약 80% 폐사를 일으키는 양이다. WSSV-infected P. vannameiLitopenaues vannamei), And obtained from Pukyong National University Department of Microbiology, The virus titer of WSSV was 1.16 x 10 < RTI ID = 0.0 >6copy / ml. Was diluted 20-fold with TNE buffer (50 mM Tris-HCl, 400 mM NaCl, 5 mM EDTA, 1 mM proteinase inhibitor PMSF, pH 8.5) and inoculated with 100 μl per 1 g of shrimp body weight using a 1 ml (26 gauge) syringe. The final concentration of shrimp inoculated WSSV was 5.8 X 103copy / 100 μl, and the virus is about 80% dead when attacked on the shrimp.
항바이러스성 식물추출물 혼합물 시료An antiviral plant extract mixture sample
아래 표 1의 식물추출물을 중앙백신연구소에서 분리 입수하였다. 상기 식물추출물은 각각 80 ~ 100% 에탄올을 사용하여 추출한 후 농축하였다. 이후 각 추출물을 물에 현탁한 후 각각 시료에 따라 EtOAC (에틸 아세테이트) 혹은 n-BuOH (부탄올)로 분획하여 식물추출액 원액을 제조하고 7종의 식물 추출물이 각각 1:1, 또는 1.0 ~ 1.5 : 1.0 ~ 3.0 상대 비율이 되도록 혼합하였다. 표 1은 실험에 사용한 식물종 및 추출조건을 나타내고, 표 2는 식물추출물의 상대적 중량비를 나타낸 것으로서, 다양한 중량비를 갖도록 제조하는 것이 가능하다.The plant extracts of Table 1 below were obtained from the Central Vaccine Research Center. The plant extracts were extracted with 80 ~ 100% ethanol and concentrated. Each of the extracts was suspended in water and then fractionated with EtOAC (ethyl acetate) or n-BuOH (butanol) according to the respective samples to prepare a plant extract solution. The extracts of 7 kinds of plant extracts were 1: 1 or 1.0-1.5: 1.0 to 3.0 relative ratios. Table 1 shows the plant species and the extraction conditions used in the experiment, and Table 2 shows the relative weight ratios of the plant extracts, and it can be manufactured to have various weight ratios.
항바이러스성 식물추출물 혼합물의 사용농도 설정Setting the concentration of the antiviral plant extract mixture
식물추출물 혼합물의 효용성을 평가하기 위해 폴리비닐알코올에 최대로 함유할 수 있는 농도를 설정하였다. 상기 폴리비닐알코올 대 식물추출물 혼합물은 최대 7:1 내지 11:1의 비율로 포함시킬 수 있었다. In order to evaluate the efficacy of the plant extract mixture, the maximum concentration of polyvinyl alcohol was set. The polyvinyl alcohol to plant extract mixture could be included at a ratio of up to 7: 1 to 11: 1.
꽃새우 및 징거미새우 입수Acquisition of the giant prawns and prawns
본 발명에서 실험에 사용된 새우는 WSSV 인공감염이 확인된 개체이다 (Experimental infection of white spot baculovirus in some cultured and wild decapods in Taiwan). 체중 약 2 ~ 3 g의 꽃새우 (Trachysalambria curvirostris)며, 약 500여 마리를 전라남도 해남에서 샘플링을 한 후, 21℃(±1℃)를 유지하면서 해수 순환시스템이 갖추어진 경상남도 통영 ㈜클로랜드로 옮겼다. 시험에 사용된 수조는 가로, 세로, 높이가 각각 60cm이며, 수조에 해수를 3분의 2가량 채운 후 온도 유지장치 (아마존, AH200)를 사용하여 수온을 21℃(±1℃) 유지하고, 시판 중인 새우사료 (대하플러스 4호, 우성사료)를 하루에 새우 평균 체중의 1%를 공급하면서 1주일 동안 변화된 환경에 안정화시켰다. 수조의 물은 상태를 모니터링하면서 1일 1회씩 물 총량의 1/3 ~ 1/4을 교체해 주었다. 도 1은 본 발명에서 사용한 꽃새우의 사진이다. The shrimp used in the experiment in the present invention are those in which WSSV artificial infection is confirmed (Experimental infection of white spot baculovirus in some cultured and wild decapods in Taiwan). (Trachysalambria curvirostris) weighing about 2 ~ 3 g and about 500 eggs were sampled in Haenam, Jeollanam-do, and then moved to Clarendon, Gyeongsangnam-do where seawater circulation system was maintained at 21 ℃ (± 1 ℃) . The water tank used for the test was 60 cm in length, length and height, and the water tank was filled with two-thirds of the seawater, and the water temperature was maintained at 21 ° C. (± 1 ° C.) using a temperature holding device (Amazon, AH 200) Commercially available shrimp feeds (
징거미 새우 (Macrobrachium nipponense)는 한국 토착형 민물새우로서 WSSV에 대한 인공감염이 확인된 개체이다 (Artificial infection of native Korean freshwater shrimp with white spot syndrome virus). 중량 약 2 ~ 4 g의 징거미 새우 약 500여 마리를 전라북도 무주에서 샘플링 하였으며, 상온 21℃ (±1℃)를 유지하면서 무주 시험장으로 옮겼다. 시험에 사용된 수조는 가로, 세로, 높이가 각각 60cm이며, 수조에 담수를 3분의 2 가량 채운 후 온도 유지장치 (아마존, AH200)를 사용하여 수온을 21℃ (±1℃)로 유지하고, 시판 중인 새우사료 (대하플러스 4호, 우성사료)를 하루에 새우 평균 체중의 1%를 공급하면서 1주일 동안 변화된 환경에 안정화시켰다. WSSV 공격접종 전 새우가 최적의 건강상태를 유지하도록 하기 위해 수온을 21℃(±1℃)로 유지하였다. 이는 WSSV의 복제가 20 ~ 25 ℃ 내외에서 이루어지는 것을 고려한 것이다. 물의 상태를 모니터링하면서 1일 1회씩 물 총량의 1/3 ~ 1/4을 교체해 주었다. WSSV 공격접종 1주일 전부터 식물추출물 혼합물이 포함된 새우사료를 새우 평균 체중의 1% 양으로 공급하였다. 도 2는 본 발명에서 사용한 징거미 새우의 사진이다.Macrobrachium nipponense is a native Korean freshwater shrimp that has been confirmed to be infected with WSSV (Artificial infection of native Korean freshwater shrimp with white spot syndrome virus). Approximately 500 shrimp weevils weighing about 2 ~ 4 g were sampled at Muju, Jeonbuk, and were transferred to the Muju test site while maintaining a temperature of 21 ℃ (± 1 ℃). The water tank used for the test was 60 cm in length, length and height, and the water tank was filled with two-thirds of the fresh water, and the water temperature was maintained at 21 ° C. (± 1 ° C.) using a temperature holding device (Amazon, AH 200) , Commercial shrimp feed (
새우에 대한 WSSV 공격접종WSSV inoculation against shrimp
WSSV 공격접종은, 1 ㎖ 주사기 (바늘직경 26G)를 사용하여 꽃새우와 징거미 새우를 각각 감염시키는 것으로 수행하였다. 주입한 WSSV의 바이러스 역가는 1.16 X 106 copy/㎖ 였으며, TNE 완충액 (50 mM Tris-HCl, 400 mM NaCl, 5 mM EDTA, 1 mM 단백질분해효소 저해제 PMSF, pH 8.5)에 20배 희석하고 1 ml 주사기를 사용하여 새우 중량 1 g당 100 ㎕를 접종하였다. 새우에 접종된 WSSV의 최종농도는 새우 1 g당 5.8 X 103 copy/㎖였으며, 이는 징거미 새우에 공격접종 했을 때 약 80% 폐사를 일으키는 양이다. Inoculation with WSSV was carried out by infecting a female shrimp and a shrimp with a 1 ml syringe (needle diameter 26G). The viral load of the injected WSSV was 1.16 × 10 6 copy / ml and diluted 20-fold in TNE buffer (50 mM Tris-HCl, 400 mM NaCl, 5 mM EDTA, 1 mM protease inhibitor PMSF, pH 8.5) ml < / RTI > per gram of shrimp weight using a syringe Lt; / RTI > The final concentration of WSSV in shrimp was 5.8 × 10 3 copy / ㎖ per 1 g of shrimp, which is about 80% mortality when attacked on the shrimp.
실험예Experimental Example
실험예 1: WSSV 공격접종Experimental Example 1: Inoculation with WSSV
각 수조 당 50마리 이상의 꽃새우 또는 징거미 새우를 각각 투입하고, 7일간 일반 사료 (대하플러스 4호, 우성사료)를 공급하여 환경에 적응시켰다. 7일 후, 각 수조에서 생존 중인 새우의 마리 수를 확인하고, 생존한 새우의 체중을 측정하였다. 공격접종용 WSSV는 1.16 X 106 copy/㎖로 stock 되었으며, 이를 TNE 완충액으로 20배 희석한 WSSV를 새우 1 g 당 100 ㎕를 사용하였으며, 새우의 배다리 상단과 가슴다리 하단 부위에 1 ㎖ 주사기 (바늘 직경 26G)로 주입하였다. 주사기 바늘은 1/3 이상이 들어가지 않도록 하였다. 시험군과 공격접종 대조군 (양성대조군) 모두 같은 방법으로 WSSV를 투여했다. 음성대조군에는 TNE 완충액만을 새우 1g당 100 ㎕ 투여했다. 모든 시험군, 양성대조군, 음성대조군은 접종 후 14일간 관찰하였다. 꽃새우와 징거미 새우를 키우는 공간에는 물을 정화시킬 수 있는 필터, 포기 스톤 (aeration stone)을 넣고 물을 순환시켜 내부의 이물질을 제거하였다. 2 ~ 3일 한번씩 물 총량의 1/3 ~ 1/4을 교체하였다. 50 shrimp or shrimp were added to each water tank, and general food (
실험예 2: Experimental Example 2: 식물추출물 혼합물을 포함한 새우용 사료 제Feed additives for shrimp including plant extract mixture 조article
식물추출물 혼합물 특유의 성분이 섭식정도에 미치는 영향을 차폐시키기 위한 방안이 필요하였다. 상기 식물추출물 혼합물의 섭식력을 높이기 위해 폴리비닐알코올 (Sigma, P8136) 대 식물추출물 혼합물 비율을 7:1 내지 11:1로 혼합하여 일반사료 (대하플러스 4호, 우성사료)에 코팅한 후, 상기 식물추출물 혼합물이 물에 바로 용해되지 않도록 하기 위해 에틸 셀룰로오스 (Duksan, 5148)로 2차 코팅하여 식물추출물 혼합물이 물에 천천히 용해되어 시험용 새우가 상기 식물추출물 혼합물로 인한 영향을 최소화하여 잘 섭식시키도록 하였다. 폴리비닐알코올 용액은 1,000 ㎖의 정제수 또는 주사용수에 폴리비닐알코올 100 g을 녹여 제조하였다. 에틸 셀룰로오스 용액은 250 ㎖ 아세톤과 250 ㎖의 100% 알코올에 49.5 g의 에틸 셀룰로오스를 녹여 제조하였다. 폴리비닐알코올 용액과 식물추출물 혼합물은 7:1 내지 11:1의 비율로 섞어 사료 총 중량의 10%를 넣어 코팅하여 24 ~ 25℃가 유지되는 건조기를 사용하여 하루 동안 완전히 건조 시킨 후 에틸 셀룰로오스 용액을 1차 코팅된 사료 총 중량의 10%를 넣어 2차 코팅이 될 수 있도록 하였다. There was a need for a way to mask the effects of specific components of the plant extract mixture on eating habits. To increase the feeding power of the plant extract mixture, the mixture ratio of polyvinyl alcohol (Sigma, P8136) to plant extract mixture was adjusted to 7: 1 to 11: 1, and the mixture was coated on a general feed (Daeha Plus No. 4, dominant feed) The plant extract mixture is secondarily coated with ethyl cellulose (Duksan, 5148) so that the plant extract mixture does not dissolve in water, so that the plant extract mixture is slowly dissolved in water to minimize the effect of the plant extract mixture on the test shrimp Respectively. The polyvinyl alcohol solution was prepared by dissolving 100 g of polyvinyl alcohol in 1,000 ml of purified water or water for injection. The ethylcellulose solution was prepared by dissolving 49.5 g of ethylcellulose in 250 mL of acetone and 250 mL of 100% alcohol. The polyvinyl alcohol solution and the plant extract mixture were mixed at a ratio of 7: 1 to 11: 1, 10% of the total weight of the feed was applied, and the mixture was thoroughly dried for 24 hours at a temperature of 24 to 25 ° C., Of the total weight of the primary coated feed was added to make a secondary coating.
상기 수득한 코팅된 본 발명의 새우사료는 식물추출물 혼합물이 갖는 특유의 향을 거의 차단할 수 있었다. 다음, 상기 코팅된 새우사료를 새우가 잘 섭취하는 지 여부를 확인하였다. 이를 위해, 하루 동안 사료를 공급하지 않은 징거미 새우를 대상으로, 새우의 활동력이 왕성한 저녁시간 (오후 6 ~ 7시)에 상기 코팅된 새우사료를 새우 총 중량의 1%를 투입하였다. 그 결과, 공급한 새우사료를 1일째 약 1/3, 2일째 약 1/2 섭취하였다. 7일간 계속하여 관찰한 결과, 상기 코팅된 새우사료를 하루 평균 약 1/2 이상 매일 섭취한 것이 확인되었다. 이는 일반사료와 비교해도 매우 우수한 섭취량이었다. The coated shrimp feed of the present invention was able to substantially block the unique flavor of the plant extract mixture. Next, it was confirmed whether the shrimp feeds the coated shrimp feed well. For this purpose, 1% of the total weight of the shrimp was added to the shrimp feed without shrimp feeding during the day, and the coated shrimp feed was added at the evening of the active shrimp (6-7 pm). As a result, the supplied shrimp feed was consumed at about 1/3 of the first day and about 1/2 of the second day. As a result of continuous observation for 7 days, it was confirmed that the coated shrimp feeds were consumed on an average of about ½ or more daily per day. This was a very good intake compared to normal feeds.
실험예 3: 징거미 새우의 WSSV 감염 확인Experimental Example 3: Confirmation of WSSV infection in the shrimp shrimp
새우에서 WSSV의 감염확인은 징거미 새우의 폐사를 통해 확인하였다. 새우의 폐사 원인이 WSSV로 인한 것인지 여부를 확인하기 위해, PCR (Polymerase chain reaction)을 수행하였다.Identification of WSSV infection in shrimp was confirmed through our company. PCR (Polymerase chain reaction) was performed to determine whether the cause of the shrimp was due to WSSV.
PCR 수행을 위해 먼저 DNA를 추출하였다. 새우의 아가미, 몸체, 배다리로부터 추출액을 수득하고, 이를 버퍼 없이 직접 균질화 한 후 1.5 ml 튜브에 넣었다. 500 ㎕ 추출 버퍼 (400 mM NaCl, 20 mM Trizma base, 5 mM EDTA, 1% SDS, PH 8.0)를 사용하여 2차 균질화 하였다. 다음, 500 ㎕의 PCI (phenol: chroloform: isoamylalcohol)를 상기 균질화된 추출액에 가하고 잘 섞어주었다. 15,800 x g (약 12,000 rpm)으로 5분간 원심분리 한 후, 상층액을 1.5 ㎖ 튜브에 옮기고, 3 M NaOAC (0.1 vol)와 100% 에탄올 (2 vol)을 첨가하였다. 다시 잘 섞은 후, -80 ℃에서 10분간 보관하였다. 다음, 18,506 X g로 30분간 원심분리한 후, 상층액을 제거한 후 실온에서 1 ~ 2분간 건조하였다. 수득한 DNA 펠릿을 20 ~ 50 ㎕의 용출 완충액에 재현탁했다. WSSV-F 프라이머 (서열번호 1: 5'-CTTTCACTTTCGGTCGTGTC-3')과 WSSV-R 프라이머 (서열번호 2: 5'-TACTCGGTCTCAGTGCCAGA-3'), 및 타겟팅 된 WSSV vp28 유전자 (604 bp)을 사용하였다. 상기 프라이머 각 1 pmol, DNA 추출물 1 ㎕ 및 증류수 7 ㎕를 사용하고, 변성 (95.0 ℃), 어닐링 (57.0 ℃), 및 길이연장 (elongation) (72.0 ℃) 조건으로 35 사이클을 반복하여 PCR을 수행하였다. DNA was first extracted for PCR. Extracts from shrimp gills, body, and pontoon were obtained, homogenized directly without buffer, and placed in 1.5 ml tubes. And homogenized using 500 μl extraction buffer (400 mM NaCl, 20 mM Trizma base, 5 mM EDTA, 1% SDS, pH 8.0). Next, 500 μl of phenol (cholloform: isoamylalcohol) was added to the homogenized extract and mixed well. After centrifugation at 15,800 x g (about 12,000 rpm) for 5 minutes, the supernatant was transferred to a 1.5 ml tube and 3 M NaOAC (0.1 vol) and 100% ethanol (2 vol) were added. After mixing again, it was stored at -80 ° C for 10 minutes. After centrifugation at 18,506 x g for 30 minutes, the supernatant was removed and dried at room temperature for 1 to 2 minutes. The obtained DNA pellet was resuspended in 20 to 50 mu l of elution buffer. The WSSV-F primer (SEQ ID NO: 1: 5'-CTTTCACTTTCGGTCGTGTC-3 ') and the WSSV-R primer (SEQ ID NO: 2'5'-TACTCGGTCTCAGTGCCAGA-3') and the targeted WSSV vp28 gene (604 bp) were used. PCR was performed by repeating 35 cycles under the conditions of denaturation (95.0 ° C.), annealing (57.0 ° C.), and elongation (72.0 ° C.) using 1 pmol of each of the above primers, 1 μl of DNA extract and 7 μl of distilled water Respectively.
WSSV 공격접종 전 징거미 새우를 샘플링하고, PCR로 WSSV 감염여부를 확인하였다. WSSV에 대한 PCR 생성물의 크기는 604 bp였으며, 이를 통해 접종 전 징거미 새우는 WSSV에 감염되지 않았음을 확인하였다. 도 6에서, 레인 1 및 2는 WSSV를 징거미 새우에 접종한 군이고, 레인 3 및 4는 WSSV 접종 전 새우에 대한 것이다. 또한, WSSV 공격접종 후, 식물추출물 혼합물 초기투입 (2 ~ 5일째), 중기투입 (6 ~ 10일째), 및 후기투입된 징거미 새우를 (11 ~ 14일째) 각각 샘플링하여, WSSV로 인한 감염여부를 확인하였다. 식물추출물 혼합물을 투입하여도 새우에 복제되어 있는 WSSV는 더 이상 증폭되지 않고 14일간 유지되는 것을 확인할 수 있었으며, 이는 식물추출물 혼합물이 WSSV 증식을 억제시키는 것으로 예상할 수 있다. 도 7은 그 결과를 나타낸다. The shrimp was sampled before the WSSV attack and confirmed by WSSV infection by PCR. The size of the PCR product for WSSV was 604 bp, confirming that the shrimp was not infected with WSSV before inoculation. In FIG. 6,
실험예 4: WSSV 공격접종 전후 폐사율 및 생존율Experimental Example 4: Mortality and Survival Rate Before and After Inoculation with WSSV
(1) 7종의 식물추출물 혼합물에 대한 꽃새우의 상대 생존율(1) Relative survival rate of ginseng to seven plant extract mixtures
WSSV 접종 전까지 생존 한 새우는 환경에 잘 적응한 개체로 판단하여 5.8 X 103 copy/㎖의 WSSV를 시험 새우 체중 1 g당 100 ㎕ 접종하고 14일간 관찰하였다. 그 결과 양성 대조군 (WSSV 접종, 일반사료 공급)에서의 누적 폐사율이 62.50%로 가장 높았으며, 본 발명의 식물추출물 혼합물의 누적 폐사율이 9.52% 내지 27.78% 이었다. 공격접종 1일차에 폐사한 시험군은 시험 결과에서 제외했다. 표 1 및 표2의 식물추출물 혼합물을 각각 포함하는 새우 사료를, WSSV 접종 전에 7일간 투입한 다음 WSSV를 접종하였으며, 접종 후에도 상기 식물추출물 혼합물을 포함하는 새우사료를 계속하여 공급하였다. The shrimp survived until the inoculation of WSSV was considered to be well adapted to the environment and 5.8 X 103 copy / ㎖ WSSV was inoculated 100 ㎕ per 1 g of the shrimp body weight and observed for 14 days. As a result, the cumulative mortality rate in the positive control group (WSSV inoculation, general feeding) was the highest at 62.50%, and the cumulative mortality rate of the plant extract mixture of the present invention was 9.52% to 27.78%. The test group that died on the first day of the attack inoculation was excluded from the test results. Shrimp feeds, each containing a mixture of plant extracts of Table 1 and Table 2, were fed for 7 days before WSSV inoculation followed by inoculation with WSSV and shrimp feed containing the plant extract mixture was continuously fed after inoculation.
또한, WSSV 접종 후 14일간 꽃새우의 누적폐사량을 통해 상대생존율을 계산하여 식물추출물 혼합물의 항바이러스 효능을 4회 반복 평가하였다. 표 2의 제조예에 따른 비율을 갖는 각 혼합물에 대해 5회 실험한 평균 값을 도 4에 나타냈다. 그 결과 누적 폐사율 대비 상대 생존율이 평균 약 76%를 넘어 상기 식물추출물 혼합물에 대한 영향으로 폐사율이 현저히 감소한 것이 확인되었다. 상대 생존율이란 [1-(식물추출물 혼합물 그룹의 누적 폐사량 %/양성 대조군의 누적 폐사량 %)]X100 이다.The antiviral efficacy of the plant extract mixture was evaluated four times by calculating the relative survival rate through the cumulative mortality of the flower fowl for 14 days after the inoculation of WSSV. FIG. 4 shows the average value of five tests for each mixture having the ratios according to the preparation examples in Table 2. [ As a result, it was confirmed that the relative survival rate to the cumulative mortality rate exceeded about 76% on average, and the mortality rate was remarkably decreased due to the effect on the plant extract mixture. Relative survival rate is [1- (cumulative mortality of plant extract mixture group / cumulative mortality of positive control group)] X100.
(2) 7종의 식물추출물 혼합물에 대한 징거미새우의 상대 생존율(2) Relative survival rate of P. japonicus shrimp on seven plant extract mixtures
본 실험예의 상기 (1)과 마찬가지로, WSSV 공격접종 전 생존한 새우의 초기 투입 수 대비 새우의 누적 폐사율을 제외하고, WSSV 공격접종 전까지 생존 한 새우는 환경에 적응한 개체로 판단하여 5.8 X 103 copy/㎖의 WSSV를 시험 새우 체중 1 g당 100 ㎕를 접종하고 14일간 관찰하였다. 그 결과 양성 대조군 (WSSV 접종, 일반사료 공급)에서의 누적 폐사율이 80.00%로 가장 높았으며, 식물추출물 혼합물의 누적 폐사율은 22.86% 내지 24.12%로 확인되었다. 시험 결과에서 공격접종 1일차에 폐사한 시험군은 시험 결과에서 제외했다. 표 1의 식물추출물 혼합물을 각각 포함하는 새우 사료를, WSSV 접종 전에 7일간 투입한 다음 WSSV를 접종하였으며, 공격 접종 후에도 상기 식물추출물 혼합물을 포함하는 새우사료를 계속하여 공급하였다. 이때 투입된 사료는 폴리비닐알코올 용액과 상기 식물추출물 혼합물을 7:1 ~ 11:1의 비율로 섞어 사료 총 중량의 약 10%를 넣어 코팅하여 24 ~ 25℃가 유지되는 건조기를 사용하여 하루 동안 완전히 건조 시킨 후 에틸 셀룰로오스 용액을 1차 코팅된 사료 총 중량의 약 10%를 넣어 2차 코팅이 된 사료를 사용하였다. 또한, WSSV 접종 후 14일간 징거미 새우의 누적폐사율을 통해 상대생존율을 계산하여 식물추출물 혼합물의 항바이러스 효능을 4회 반복 평가하였다. 표 2의 제조예에 따른 비율을 갖는 각 혼합물에 대해 4회 실험한 평균 값을 도 4에 나타냈다. 그 결과 본 발명의 식물추출물 혼합물의 상대 생존율이 약 71%를 넘었으며, 상기 식물추출물 혼합물에 대한 영향으로 폐사율이 현저히 감소한 것이 확인되었다. 상대 생존율이란 [1-(식물추출물 혼합물 그룹의 누적 폐사량 %/양성 대조군의 누적 폐사량 %)]X100 이다. As with the experiment examples above (1), WSSV attack inoculation before the initial injection of the surviving shrimp except cumulative mortality against shrimp, survival until WSSV attack vaccinated shrimp is determined by the objects adapted to the environment, 5.8 X 10 3 The copy / ml WSSV was inoculated 100 당 per 1 g of the test shrimp body weight and observed for 14 days. As a result, the cumulative mortality rate in the positive control (WSSV inoculation, general feed) was the highest at 80.00%, and the cumulative mortality rate of the plant extract mixture was found to be 22.86% to 24.12%. In the test results, the test group that died on the first day of the attack inoculation was excluded from the test results. The shrimp feeds, each containing the plant extract mixture of Table 1, were fed for 7 days before WSSV inoculation followed by inoculation with WSSV and shrimp feeds containing the plant extract mixture were continuously fed after challenge. The feeds were prepared by mixing 10% of the total weight of the feed with the polyvinyl alcohol solution and the plant extract mixture at a ratio of 7: 1 to 11: 1, After drying, about 10% of the total weight of the primary coated feed was added to the ethyl cellulose solution, and the secondary coated feed was used. In addition, the relative survival rate was calculated by multiplying the cumulative mortality of shrimp shrimp for 14 days after the inoculation of WSSV to evaluate the antiviral efficacy of the plant extract mixture four times. 4 shows the average value obtained by four experiments for each mixture having the ratio according to the preparation example of Table 2. [ As a result, the relative survival rate of the plant extract mixture of the present invention exceeded about 71%, and it was confirmed that the mortality rate was remarkably decreased due to the effect on the plant extract mixture. Relative survival rate is [1- (cumulative mortality of plant extract mixture group / cumulative mortality of positive control group)] X100.
(3) 식물추출물 혼합물 코팅농도에 대한 징거미새우의 상대 생존율 (3) Relative survival rate of P. japonicus shrimp to plant extract mixture coating concentration
식물추출물 혼합물의 농도를 달리하면서 농도별 상대 생존율을 확인하였다.The relative survival rate of each plant was determined by varying the concentration of the plant extract mixture.
본 실험예의 상기 (1)과 마찬가지로, WSSV 공격접종 전 생존한 새우의 초기 투입 수 대비 새우의 누적 폐사율을 제외하고, WSSV 공격접종 전까지 생존 한 새우는 환경에 적응한 개체로 판단하여 5.8 X 103 copy/㎖의 WSSV를 시험 새우 체중 1 g당 100 ㎕를 접종하고 14일간 관찰하였다. 그 결과 양성 대조군 1 (WSSV 접종, 일반사료 공급)에서의 누적 폐사율이 68.00%로 가장 높았으며, 식물추출물 혼합물은 30 ~ 300 ㎎/㎖ 농도에서 가장 낮은 누적 폐사율을 보였으며 이 범위를 벗어난 경우 양성대조군 수준 이상으로 폐사율이 증가하였다. As with the experiment examples above (1), WSSV attack inoculation before the initial injection of the surviving shrimp except cumulative mortality against shrimp, survival until WSSV attack vaccinated shrimp is determined by the objects adapted to the environment, 5.8 X 10 3 The copy / ml WSSV was inoculated 100 당 per 1 g of the test shrimp body weight and observed for 14 days. As a result, the cumulative mortality rate in the positive control group 1 (WSSV inoculation, general feeding) was the highest at 68.00%, and the plant extract mixture showed the lowest cumulative mortality at the concentration of 30 ~ 300 ㎎ / ㎖. The mortality rate was higher than the control level.
본 발명은, 갑각류에 감염시 심각한 손해를 초래할 수 있는 흰점 바이러스에 활성이 있는 항바이러스 물질을 제공한다. 따라서, 본 발명은 새우를 포함한 갑각류 양식장에 널리 활용될 수 있을 것이다.The present invention provides antiviral agents that are active against white spot viruses that can cause serious damage when infected with crustaceans. Therefore, the present invention can be widely used in crustacean farms including shrimp farms.
<110> Choong Ang Vaccine Lab. <120> A composition having antiviral activity for white spot syndrome virus <130> CVA17P-0008-KR <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> WSSV-F primer <400> 1 ctttcacttt cggtcgtgtc 20 <210> 2 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> WSSV-R primer <400> 2 tactcggtct cagtgccaga 20 <110> Choong Ang Vaccine Lab. <120> A composition having antiviral activity for white spot syndrome virus <130> CVA17P-0008-KR <160> 2 <170> KoPatentin 3.0 <210> 1 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> WSSV-F primer <400> 1 ctttcacttt cggtcgtgtc 20 <210> 2 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> WSSV-R primer <400> 2 tactcggtct cagtgccaga 20
Claims (17)
상기 식물추출물의 혼합물은 관중추출물 : 크레이스토카릭스 오페르쿠라투스 추출물 : 칠엽수 추출물 : 감초 추출물 : 울금 추출물 :백지 추출물 : 동백 추출물 = 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0의 중량비를 갖는 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료, 또는 예방 및 치료하기 위한 조성물. The method according to claim 1,
1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 3.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: Wherein the composition has a weight ratio of 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0, to prevent, treat or prevent the infection of crustaceans caused by white spot virus.
상기 추출물의 혼합물이 상기 조성물을 기준으로 30 ~ 300 ㎎/㎖ 포함된 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료, 또는 예방 및 치료하기 위한 조성물.3. The method according to claim 1 or 2,
A composition for preventing, treating, or preventing and treating a crustacean infection caused by white spot virus, wherein a mixture of said extract is contained in an amount of 30 to 300 mg / ml based on said composition.
상기 추출물의 혼합물이 고분자 물질로 코팅된 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료, 또는 예방 및 치료하기 위한 조성물. 3. The method according to claim 1 or 2,
A composition for preventing, treating, or preventing and treating a crustacean infection caused by a white spot virus, characterized in that the mixture of the extract is coated with a polymer material.
상기 코팅이 친수성 고분자에 의한 1차 코팅 및 비친수성 고분자에 의한 2차 코팅으로 구성된 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료, 또는 예방 및 치료하기 위한 조성물. 5. The method of claim 4,
A composition for preventing, treating or preventing and treating infections of crustaceans caused by white spot virus, characterized in that the coating consists of a primary coating with a hydrophilic polymer and a secondary coating with a non-hydrophilic polymer.
상기 갑각류가 새우인 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료, 또는 예방 및 치료하기 위한 조성물. 3. The method according to claim 1 or 2,
A composition for preventing, treating, or preventing and treating infection of crustaceans by white spot virus, characterized in that said crustaceans are shrimp.
상기 식물추출물의 혼합물은 관중추출물 : 크레이스토카릭스 오페르쿠라투스 추출물 : 칠엽수 추출물 : 감초 추출물 : 울금 추출물 :백지 추출물 : 동백 추출물 = 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0의 중량비를 갖는 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료 또는 예방 빛 치료하는 방법. 8. The method of claim 7,
1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 3.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0. A method for preventing, treating or preventing photophobia of a crustacean caused by white spot virus.
상기 혼합용액을 사료와 혼합한 후 건조하여, 상기 혼합물과 사료가 고분자 물질로 코팅된 사료 조성물을 수득하며,
상기 사료 조성물을, 흰반점 바이러스에 의한 감염을 예방, 치료 또는 예방 및 치료가 필요한 갑각류에 피딩 (feeding) 하는 것을 포함하여,
흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료 또는 예방 및 치료하는 방법.A mixed solution of a mixture of a crowd, Craystokarix auxercuratus, cherry tree, licorice, kelp, white paper and camellia extract and a polymer substance was prepared.
The mixed solution is mixed with a feed and dried to obtain a feed composition in which the mixture and the feed are coated with a polymer material,
Comprising feeding said feed composition to a crustacean which is required to prevent, cure or prevent and treat infections caused by white spot viruses,
A method for preventing, treating or preventing an infection of a crustacea caused by a white spot virus.
상기 식물추출물의 혼합물은 관중추출물 : 크레이스토카릭스 오페르쿠라투스 추출물 : 칠엽수 추출물 : 감초 추출물 : 울금 추출물 :백지 추출물 : 동백 추출물 = 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0 : 1.0 ~ 3.0의 중량비를 갖는 것을 특징으로 하는, 흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료 또는 예방 및 치료하는 방법.10. The method of claim 9,
1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 3.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0: 1.0 to 3.0. A method for preventing, treating, or preventing and treating infection of crustaceans by white spot virus.
상기 코팅이 친수성 고분자에 의한 1차 코팅 및 비친수성 고분자에 의한 2차 코팅으로 구성된 것을 특징으로 하는,
흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료 또는 예방 및 치료하는 방법.10. The method of claim 9,
Characterized in that the coating comprises a primary coating with a hydrophilic polymer and a secondary coating with a non-hydrophilic polymer.
A method for preventing, treating or preventing an infection of a crustacea caused by a white spot virus.
상기 추출물의 혼합물이 상기 조성물을 기준으로 30 ~ 300 ㎎/㎖ 포함된 것을 특징으로 하는,
흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료 또는 예방 및 치료하는 방법.9. The method according to claim 7 or 8,
Characterized in that a mixture of said extracts comprises 30 to 300 mg / ml, based on said composition.
A method for preventing, treating or preventing an infection of a crustacea caused by a white spot virus.
상기 추출물의 혼합물이 상기 조성물을 기준으로 30 ~ 300 ㎎/㎖ 포함된 것을 특징으로 하는,
흰반점 바이러스에 의한 갑각류의 감염을 예방, 치료 또는 예방 및 치료하는 방법.12. The method according to any one of claims 9 to 11,
Characterized in that a mixture of said extracts comprises 30 to 300 mg / ml, based on said composition.
A method for preventing, treating or preventing an infection of a crustacea caused by a white spot virus.
The inhibitory activity against white spot viruses, including phlebotomists, a mixture of Crestor Carrícís auxercuratus, cherries, licorice, ugly, white and camellia extracts, and pharmacological, veterinary or agriculturally acceptable carriers or diluents ≪ / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170022579A KR101934350B1 (en) | 2017-02-20 | 2017-02-20 | A composition having antiviral activity for white spot syndrome virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170022579A KR101934350B1 (en) | 2017-02-20 | 2017-02-20 | A composition having antiviral activity for white spot syndrome virus |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180096201A true KR20180096201A (en) | 2018-08-29 |
KR101934350B1 KR101934350B1 (en) | 2019-01-02 |
Family
ID=63434657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170022579A KR101934350B1 (en) | 2017-02-20 | 2017-02-20 | A composition having antiviral activity for white spot syndrome virus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101934350B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107260948A (en) * | 2017-06-27 | 2017-10-20 | 宁国市仙之居家庭农场 | The Chinese herbal feed additive and preparation method of a kind of rice shrimp aquaculture |
KR101989349B1 (en) * | 2018-03-12 | 2019-06-14 | 강릉원주대학교 산학협력단 | Composition for treating and preventing viral infection comprising extracts from Camellia japonica |
KR20200029703A (en) * | 2018-09-11 | 2020-03-19 | 동의대학교 산학협력단 | Feed additive composition for macrobrachium rosenbergii |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040088637A (en) | 2003-04-10 | 2004-10-20 | 에스케이 텔레콤주식회사 | System and Method for Call Connection with Capacity Extension of Mobile Identification Number |
KR20060048317A (en) | 2004-06-11 | 2006-05-18 | 가부시키가이샤 시마노 | Treble hook |
KR20060048780A (en) | 2004-07-26 | 2006-05-18 | 구글, 인코포레이티드 | Phrase-based indexing in an information retrieval system |
KR20140128540A (en) | 2013-04-26 | 2014-11-06 | 주식회사 유비유이노베이션 | Assets and security management system and method in realtime using rfid active tag |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100573759B1 (en) | 2004-11-03 | 2006-04-24 | 주식회사 베터앤베터 | An animal feed additive having immune stimulating effects on white spot syndrome virus(wssv) |
KR101021830B1 (en) | 2010-08-17 | 2011-03-17 | 주식회사 중앙백신연구소 | Antiviral agents with inhibitory activities on avian and swine influenza virus or novel influenza virus by compounds isolated from cleistocalyx operculatus |
-
2017
- 2017-02-20 KR KR1020170022579A patent/KR101934350B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040088637A (en) | 2003-04-10 | 2004-10-20 | 에스케이 텔레콤주식회사 | System and Method for Call Connection with Capacity Extension of Mobile Identification Number |
KR20060048317A (en) | 2004-06-11 | 2006-05-18 | 가부시키가이샤 시마노 | Treble hook |
KR20060048780A (en) | 2004-07-26 | 2006-05-18 | 구글, 인코포레이티드 | Phrase-based indexing in an information retrieval system |
KR20140128540A (en) | 2013-04-26 | 2014-11-06 | 주식회사 유비유이노베이션 | Assets and security management system and method in realtime using rfid active tag |
Non-Patent Citations (2)
Title |
---|
Artificial infection of native Korean freshwater shrimp with white spot syndrome virus (WSSV). |
Experimental infection of white spot baculovirus in some cultured and wild decapods in Taiwan. |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107260948A (en) * | 2017-06-27 | 2017-10-20 | 宁国市仙之居家庭农场 | The Chinese herbal feed additive and preparation method of a kind of rice shrimp aquaculture |
KR101989349B1 (en) * | 2018-03-12 | 2019-06-14 | 강릉원주대학교 산학협력단 | Composition for treating and preventing viral infection comprising extracts from Camellia japonica |
KR20200029703A (en) * | 2018-09-11 | 2020-03-19 | 동의대학교 산학협력단 | Feed additive composition for macrobrachium rosenbergii |
Also Published As
Publication number | Publication date |
---|---|
KR101934350B1 (en) | 2019-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210046131A1 (en) | Wide-spectrum salmonella phage and application thereof | |
Seng | Control of parasites in cultured marine finfishes in Southeast Asia—an overview | |
Bourne et al. | Microbial community dynamics in a larval aquaculture system of the tropical rock lobster, Panulirus ornatus | |
JP4977011B2 (en) | Prevention method for crustacean mold and fish mold using Bacillus subtilis | |
KR101335825B1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
CN112029732A (en) | High-temperature-resistant salmonella bacteriophage with wide lysis spectrum and composition thereof | |
KR101934350B1 (en) | A composition having antiviral activity for white spot syndrome virus | |
US20140105866A1 (en) | Bacteriophages useful for the prophylaxis and therapy of vibrio anguillarum | |
JP4105535B2 (en) | Antiviral substance | |
CN113201505B (en) | Vibrio alginolyticus phage with cross-species lysis capability, phage composition and application thereof | |
CN104887843A (en) | Chinese medicinal composition for prevention and treatment of fish gill rot disease and preparation method thereof | |
Citarasu et al. | Effect of wood apple Aegle marmelos, Correa (Dicotyledons, Sapindales, Rutaceae) extract as an antibacterial agent on pathogens infecting prawn (Penaeus indicus) larviculture | |
CN111110718B (en) | Special pesticide for prawn enterocytocele and preparation method and application thereof | |
WO1998042204A1 (en) | Infectious disease preventive/remedy for fishes and shellfishes | |
CN111363723A (en) | Novel vibrio cholerae bacteriophage and application thereof | |
CN115247154B (en) | Duck-derived clostridium welchii phage vB_CpeP_PM13, phage composition and application thereof | |
KR102371062B1 (en) | Feed additive composition for shrimp farming and manufacturing method thereof | |
US20070218036A1 (en) | Method For The Prevention Of Infection With Nodavirus And Method For The Treatment Thereof | |
CN115181731B (en) | Vibrio parapsilosis phage, preparation method and application thereof | |
CN115216453B (en) | Edwardsiella specific phage, composition and application thereof | |
CN115247155B (en) | Mermaid luminous bacillus bacteriophage, bacteriophage composition and application thereof | |
CN114848616B (en) | Application of cuminalin in preparation of white spot syndrome virus inhibitor | |
Maeda | Interactions of microorganisms and their use as biocontrol agents in aquaculture | |
JP4294326B2 (en) | Agents for preventing and / or treating seafood infections | |
Novriadi et al. | Preliminary study: The use of herbal extracts against iridovirus in tiger grouper Epinephelus Fuscoguttatus culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |